Several studies, however, over the past 20 years have suggested potential genomic actions of oestrogen in colon cancer that could underpin sex differences: oestrogen may promote or inhibit cell proliferation and reduce or stimulate cell death (apoptosis) depending on the ER subtype expression in colon cancer cells (Figure 3) [67]. Here, ESR1 is linked to malignant colon neoplasm.